Abstract
Myasthenia gravis is an autoimmune disease resulting from a breakdown in T and B cell tolerance to acetylcholine receptor (AChR). Autoantibodies to AChR mediate the disease. Recent advances in experimental immunotherapy of autoimmune disease provide several possibilities for specific intervention in this well-characterized condition.
| Original language | English |
|---|---|
| Pages (from-to) | 2726-2731 |
| Number of pages | 6 |
| Journal | FASEB Journal |
| Volume | 4 |
| Issue number | 10 |
| Publication status | Published - 1990 |
Keywords
- antibodies
- autoimmune response
- immunotherapy
- myasthenia gravis
- T cell tolerance
ASJC Scopus subject areas
- Agricultural and Biological Sciences (miscellaneous)
- Biochemistry, Genetics and Molecular Biology(all)
- Biochemistry
- Cell Biology